Topic: Advocacy & Support, Awareness & Community, Life & Wellness, Medical Knowledge, News & Events

May 2024

Anifrolumab (Saphnelo) in PEI

April 23, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in PEI effective April 23, 2024.

For more information, please visit the PEI Pharmacare Program website.

< Back to Main List Next Article >

Lupus Blog Articles:

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Advocacy & Support Community & Awareness

LIVING WITH LUPUS | Elizabeth L.

Awareness & Community Personal Stories

Living with Lupus Corner with Mauricia Ambrose | Summer is Here!

Awareness & Community Life & Wellness